Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

NCT04200989 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Food Allergy Peanut

Interventions

BIOLOGICAL: Peanut allergen

Sponsor

Scripps Health

Collaborators

[object Object]